Perrigo Company PLC (PRGO): Fair Value Consensus

Corporate company logo of Perrigo Company PLC (PRGO)

The market dynamics of Perrigo Company plc (PRGO) demonstrate a current indicator of 16.96. Perrigo Company plc sources raw materials from external suppliers while maintaining strict oversight of product quality. Production capacities for baby food and pharmaceuticals are being upgraded through shop-floor automation. The business relies on its status as a key partner for pharmacy chains, supplying the market with affordable private-label products.

Perrigo Company (PRGO) Price Target Chart: for the period 07/04/2022 - 11/11/2026
Flagship merchandise of Perrigo Corp

The average analyst target synthesizes market expectations for future cash flows, neutralizing the time lag associated with standard financial reporting. This metric measures the aggregate fundamental value of the asset through the averaged valuations of professional experts. The price action of the consensus forecast indicator reflects market optimism regarding the resilience of Perrigo Company plc (PRGO). A focus on Private Label healthcare makes this forecast less volatile, while stable demand for economy brands confirms the defensive qualities of the investment.

Competitors of Perrigo Company plc

HLN: Forecast Levels Chart|Price Target Chart Kenvue KVUE|Fair Value Consensus VRNA|Jyong Biotech Corp - Analyst Consensus Forecast|Analyst Target Range Ligand Corp (LGND)|Amneal Pharmaceuticals (AMRX) - Price Target Chart|Average Forecast Price alvotech.com (ALVO)|Price Target Chart Liquidia|Galapagos N.V. - Forecast Levels Chart|Analyst Consensus Forecast ANIP|MNKD (Afrezza) - Fair Value Consensus|Analyst Consensus Forecast AMPH (Amphastar Pharmaceuticals)|Analyst Consensus Forecast pacira.com PCRX|SPRY - Price Target Chart|Fair Value Consensus TBPH (Theravance Biopharma Inc)|Aquestive Pharma (AQST) - Price Target Chart|Consensus Target scPharmaceuticals|TECX (Tectonic Therapeutic Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast tonixpharma.com|Consensus Target SXTC (China SXT Pharmaceuticals)|EPRX (eupraxiapharma.com) - Fair Value Consensus|Price Target Chart BioHarvest BHST|Invizyne (EXOZ) - Average Forecast Price|ORMP: Consensus Target|Entera Bio Ltd. - Analyst Forecast Prices|HYFT: Analyst Consensus Forecast|ABVC BioPharma Inc. - Fair Value Consensus|CPIX (Cumberland Pharma) - Analyst Consensus Forecast|Average Forecast Price Quantum BioPharma Corp QNTM|Price Target Chart FibroGen, Inc. (FGEN)|TELO (telomirpharma.com) - Fair Value Consensus|Price Target Chart Rani Therapeutics Holdings, Inc. RANI|SNYR (Synergy CHC Corp.) - Forecast Levels Chart|Rallybio Corp. - Analyst Consensus Forecast|Average Forecast Price Lexaria Bioscience|Pulmatrix, Inc. (PULM) - Price Target Chart|Pheton Holdings - Fair Value Consensus|Price Target Chart Aptorum Group Ltd|LYRA: Fair Value Consensus|Analyst Consensus Forecast IBO|Analyst Median Target tnfpharma.com|Analyst Consensus Forecast YCBD (cbdMD)|Analyst Target Range painreform.com|CYTO - Price Target Chart|Average Forecast Price Lipella Pharmaceuticals Inc|OPTN (Optinose) - Consensus Target|Pieris Pharma - Fair Value Consensus|PROC (Procaps Group S.A.) - Analyst Consensus Forecast|Consensus Target petrospharma.com (PTPI)|Price Target Chart Qilian International Holding (QLI)|SLRN - Average Forecast Price|Price Target Chart TFF Pharma TFFP